Kangmei Pharma | 600518 - Operating Expenses


Kangmei Pharma reported CNY1.22B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.01M 175K Mar/2026
Avita Medical AUD 28.02M 1.55M Dec/2025
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Dianthus Therapeutics USD 47M 22.83M Mar/2026
Genomma Lab Internacional MXN 3.64B 121.55M Sep/2026
Hypermarcas BRL 1.51B 77.98M Mar/2026
Ionis Pharmaceuticals USD 370.24M 6.24M Jun/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Jiangsu Hengrui CNY 6.01B 449.22M Sep/2026
Kangmei Pharma CNY 1.22B 130.32M Jun/2026
Moderna USD 960M 817M Jun/2026
Organon & Co USD 1.19B 187M Sep/2026
Revvity USD 603.55M 24.8M Jun/2026
Sh Fosun Pharma CNY 9.09B 637.86M Sep/2026
Tectonic Therapeutic USD 27.3M 5.78M Mar/2026
Viatris USD 3.68B 145.9M Jun/2026
Wuxi Apptec CNY 9.07B 580.89M Sep/2026
Xeris Pharmaceuticals USD 75.21M 6.18M Mar/2026
Zz Pientze Pharmaceu CNY 1.45B 431.06M Jun/2026